Trial Profile
A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight Loss
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Aug 2018
Price :
$35
*
At a glance
- Drugs Orlistat (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 25 Jan 2010 Results published in Archives of Internal Medicine.
- 20 Oct 2007 Interim results were reported at the 2007 Annual Meeting of the North American Association for the Study of Obesity.
- 05 Jul 2007 Status changed from recruiting to completed.